Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Angiodroid logo — Automated Carbon Dioxide Angiography with Angiodroid the CO2...

Angiodroid

Automated Carbon Dioxide Angiography with Angiodroid the CO2 Injector

Founded 2013 Italy Italy 43 employees Series A Total: $10.40M Health Care, Medical Devices

General Information

Company Name Angiodroid
Founded Year 2013
Location Italy Italy
Employees 43
Industries Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Angiodroid. To contact Angiodroid, visit angiodroid.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Angiodroid compare?

A PDF of Angiodroid and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Angiodroid soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Angiodroid

Angiodroid SpA, an Italian innovative Company founded in 2013, specializes in providing solutions for the medical market with their main product, Angiodroid® The CO2 Injector. This device is a Carbon Dioxide (CO2) Injector designed for Interventional Radiology procedures, offering an ideal solution for patients at risk of Contrast Induced Nephropathy (CIN), Diabetic Disease, Renal Failure, and those with intolerance to Iodinated contrast media. The company addresses the limitations of manual injection kits by introducing the only injector that is 100% automatic, safe, digital, and user-friendly. With a recent €7.00M Series A investment secured on 27 February 2023, by 8a + INVESTMENTS, Air Liquide, and CDP Venture Capital, Angiodroid is well-positioned to further develop and expand its presence in the Health Care industry. For more information, visit www.angiodroid.com.

Business keywords: Medical technology, Interventional radiology, Vascular surgery, CO2 Injector, Medical devices, Innovative solutions, Digital healthcare, Patient safety, Contrast media, Automated technology, Italian medical company

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €7.00M 3
8a + INVESTMENTS Air Liquide
8a + INVESTMENTS, Air Liquide +1
27 Feb 2023
Venture Round €1.50M 2
Innogest Capital Italian Angels for Growth
Innogest Capital, Italian Angels for Growth
17 Jul 2015
Seed Round €1.90M 4
Italian Angels for Growth Embed Capital
Italian Angels for Growth, Embed Capital +2
22 Oct 2013

Angiodroid Alternatives & Competitors

View All Alternatives
Angiodroid vs
VeinWay Ltd.
VeinWay Ltd. Israel

Changing the paradigm on treating chronic venous disease.

Series A
9 employees
Health Care, Medical Devices
Compare Angiodroid vs VeinWay Ltd.
Angiodroid vs
Lydus Medical
Lydus Medical Israel

Automated micro anastomosis for ultra-small vessels

Seed
7 employees
Health Care, Medical Devices
Compare Angiodroid vs Lydus Medical
Angiodroid vs
Q3 Medical Group
Q3 Medical Group Ireland

Creating Value By Helping People

Venture round
59 employees
Health Care, Medical Devices
View all alternatives

FAQ About Angiodroid

Automated Carbon Dioxide Angiography with Angiodroid the CO2 Injector
Angiodroid was founded in 2013.
Angiodroid is headquartered in Italy.
Angiodroid operates in Health Care and Medical Devices. Its work centres on Medical technology, Interventional radiology, Vascular surgery and CO2 Injector.
Angiodroid has approximately 43 employees.
Angiodroid has completed 3 funding rounds, raising a total of $10.40M. The latest funding stage is Series A.
Top alternatives and competitors to Angiodroid include VeinWay Ltd., Lydus Medical, Q3 Medical Group, Spartan Micro, Inc., Blueneem Medical Devices Pvt Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Angiodroid and VeinWay Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Angiodroid, https://www.bouncewatch.com/company/angiodroid, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout